CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $343,325,294
- in 74 filings, $342.5M under 10b5-1 plans
Net −$343,325,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −546 | $314.18 | $172K | 3,184 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −563 | $314.99 | $177K | 2,621 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −590 | $316.14 | $187K | 2,031 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $317.26 | $203K | 1,391 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,119 | $318.22 | $356K | 272 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −142 | $318.90 | $45K | 130 |
| 2024-06-27 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Options 10b5-1 | −3,600 | 144,269 | ||
| 2024-06-26 | MALCOLM JAN Director | Grant or award · Stock Options | +1,520 | 1,520 | ||
| 2024-06-26 | MALCOLM JAN Director | Grant or award · Restricted Stock Unit | +630 | 630 | ||
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +3,600 | $129.49 | $466K | 3,730 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −449 | $316.38 | $142K | 3,281 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,873 | $318.14 | $596K | 1,408 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −958 | $319.00 | $306K | 450 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −192 | $320.39 | $62K | 258 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −128 | $320.88 | $41K | 130 |
| 2024-06-26 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Options 10b5-1 | −3,600 | 147,869 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Stock Options | +99,720 | 99,720 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Restricted Stock Units | +15,592 | 15,592 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Restricted Stock Units | +17,790 | 17,790 | ||
| 2023-03-15 | EDGEMOND JAMES CFO AND TREASURER | Grant or award · Stock Options | +58,170 | 58,170 |
Page 267 of 268 · 5,348 trades